SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio December 1, 2025
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty November 26, 2025